Imaging technology for Cancer treatment

WALTHAM, US: PerkinElmer, Inc., a player focused on the health and safety of people and the environment, today announced that it has entered into a joint technology development and marketing agreement with LinaTech, a lmanufacturer of medical devices and software for treating cancer with radiotherapy.

The intent of the collaboration is to develop, implement, market and distribute imaging technologies for the treatment of certain types of cancer. The products to be developed include cost-effective imaging solutions that allow customers to upgrade their legacy film-based radiotherapy systems, and also include imaging subsystems for sales to radiotherapy system manufacturers. The first generation product, the FDA 510k-approved LinaTech TiGRT Image Viewing System, will be showcased at the American Society of Therapeutic Radiology and Oncology in San Diego next week.

Brian Giambattista, president, Medical Imaging, PerkinElmer, said, "PerkinElmer is very pleased to be working with LinaTech, with its strong track record of successful innovation in radiotherapy solutions and systems. We look forward to very compelling outcomes from our development project, as we seek to create new technologies for the benefit of cancer patients, by giving doctors and hospitals more imaging options."

Jonathan Yao, president of LinaTech, said, "We are delighted to collaborate with a global leader of PerkinElmer's reputation for quality product development, along with unmatched worldwide reach in imaging. We feel that both companies will strongly complement each other as we work toward better solutions for oncology treatment."